A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas
Jennifer Permuth‐Wey(Moffitt Cancer Center), Mokenge P. Malafa(Moffitt Cancer Center), Y. Ann Chen(Zhejiang Chinese Medical University), Barbara A. Centeno(Moffitt Cancer Center), Kavita Ghia(Moffitt Cancer Center), Christina Georgeades(Medical College of Wisconsin), Gregory M. Springett(Moffitt Cancer Center), Vonetta L. Williams(Moffitt Cancer Center), Mark C. Lloyd(Moffitt Cancer Center), Funmilayo Olaoye(Moffitt Cancer Center), Sean Yoder(Moffitt Cancer Center), Kazim Husain(Moffitt Cancer Center), Domenico Coppola(Florida College), Laura Hall(California Polytechnic State University), Kate Fisher(International Drug Development Institute (Belgium)), Jason Klapman(Susan Thompson Buffett Foundation), Michelle Fournier(Moffitt Cancer Center), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Susan McCarthy(University of South Florida), Dung‐Tsa Chen(Moffitt Cancer Center), Timothy J. Yeatman(University of South Florida), Agnieszka Kasprzak(Moffitt Cancer Center)
Cited by 51
Related Papers
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k